Shujing Shen

Jianshe East Road 1
Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Dosimetric comparison of three different radiotherapy regimens for bilateral breast cancer.

Dosimetric comparison of three different radiotherapy regimens for bilateral breast cancer.

Journal: Biomedical engineering online

Published: July 03, 2025

Camrelizumab combined with anlotinib as second-line therapy for metastatic or recurrent small cell lung cancer: a retrospective cohort study.

Camrelizumab combined with anlotinib as second-line therapy for metastatic or recurrent small cell lung cancer: a retrospective cohort study.

Journal: Frontiers in oncology

Published: April 23, 2024

Response to immune checkpoint inhibitor combination therapy in metastatic RET-mutated lung cancer from real-world retrospective data.

Response to immune checkpoint inhibitor combination therapy in metastatic RET-mutated lung cancer from real-world retrospective data.

Journal: BMC cancer

Published: November 07, 2023

Efficacy of immune checkpoint inhibitors in advanced large cell neuroendocrine carcinoma of the lung: A single‑institution experience.

Efficacy of immune checkpoint inhibitors in advanced large cell neuroendocrine carcinoma of the lung: A single‑institution experience.

Journal: Oncology letters

Published: August 29, 2023

Successful treatment of lung adenocarcinoma complicated with a rare compound EGFR mutation L833V/H835L using aumolertinib: a case report and literature review.

Successful treatment of lung adenocarcinoma complicated with a rare compound EGFR mutation L833V/H835L using aumolertinib: a case report and literature review.

Journal: Frontiers in pharmacology

Published: July 12, 2023

Corrigendum: Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report.

Corrigendum: Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report.

Journal: Frontiers in medicine

Published: July 11, 2023

Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report.

Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report.

Journal: Frontiers in medicine

Published: December 22, 2022

BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective.

BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective.

Journal: Frontiers in oncology

Published: January 26, 2022

Alectinib versus crizotinib in ALK-positive advanced non-small cell lung cancer and comparison of next-generation TKIs after crizotinib failure: Real-world evidence.

Alectinib versus crizotinib in ALK-positive advanced non-small cell lung cancer and comparison of next-generation TKIs after crizotinib failure: Real-world evidence.

Journal: Cancer medicine

Published: January 04, 2022

Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M.

Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M.

Journal: BMC cancer

Published: July 08, 2021

Characteristics of Epidermal Growth Factor Receptor with Rare Mutations in Non-small Cell Lung Cancer and the Effect of EGFR Tyrosine Kinase Inhibitors on Them

Characteristics of Epidermal Growth Factor Receptor with Rare Mutations in Non-small Cell Lung Cancer and the Effect of EGFR Tyrosine Kinase Inhibitors on Them

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: May 22, 2019

Association between the HER2 Gene Status and the Efficacy of First-line Pemetrexed Combined with Platinum Chemotherapy in Patients with Advanced Lung  Adenocarcinoma

Association between the HER2 Gene Status and the Efficacy of First-line Pemetrexed Combined with Platinum Chemotherapy in Patients with Advanced Lung  Adenocarcinoma

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: March 27, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026